By not doing so, doctors also couldnt warn their patients of the potential exacerbation of their gastroparesis if they already were suffering from it so that they could make an informed decision about whether to take the drug By 2022, researchers additionally tied gallbladder issues to this class of drugs, which opened the door to the first round of lawsuits against manufacturers
When combined with GLP-1s, it may offer complementary mechanisms that help regulate metabolism and weight, resulting in potentially more robust weight loss
HernandezAFGreenJBJanmohamedSD'Agostino RBSrGrangerCBJonesNPet alAlbiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (harmony outcomes): a double-blind, randomised placebo-controlled trial
Bottom Line Dry mouth, bad breath, and taste changes can show up with GLP-1s, even without hard proof the medication causes them directly
This becomes relevant for diabetes because blocking the SGLT2, and therefore preventing that reabsorption, allows excess glucose to be excreted in the urine rather than returned to the bloodstream
